Physician profile
Brian Minow
NPI 1518395623
$2,277.23
in general payments reported to CMS, 2019-2025
12 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $843 · 2021: $152 · 2022: $100 · 2023: $107 · 2024: $457 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $799.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $940.23 | 2019-2021 | |
| Smith+Nephew, INC. | $319.43 | 2019-2025 | Grafix Pl |
| Ets Wound Care LLC | $258.59 | 2024 | Mirragen Advanced Wound Matrix |
| Mimedx Group, INC. | $251.34 | 2024-2025 | |
| Organogenesis INC. | $200.47 | 2019-2025 | Puraply, Cygnus Dual |
| Kci USA, INC. | $122.22 | 2019-2023 | Silvercel, Promogran Prisma, Activ.A.C. |
| Urgo Medical North America, LLC | $81.71 | 2025 | Urgoclean Ag |
| Hydrofera LLC | $33.03 | 2023 | Hydrofera Blue |
| Convatec INC. | $26.97 | 2021-2022 | |
| Solventum Corporation | $17.14 | 2024 | Promogran Prisma, Activ.A.C., Kerramax Care |
| Coloplast Corp | $15.10 | 2025 | |
| Celularity INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Minow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.